Michelle McMurry-Heath, BIO CEO (BIO)
BIO and a string of CEOs issue a call for FDA independence and against science-by-press-release
It appears to be open letter week in biotech.
On Sunday, Scripps Research’s Eric Topol penned a scathing letter in
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
